I focus my practice on all services relating to biotechnology and life sciences patents, including patent application drafting and prosecution, patent counseling and strategic planning, patentability opinions and freedom-to-operate opinions. I have a technical background in molecular biology, cell biology, genetics, genomics, cell signaling, cancer biology, stem cell biology and agricultural biotechnology. I have extensive experience drafting and prosecuting patent applications in technologies directed to genome editing, CRISPR-Cas technology, and transgenic organisms. I also have extensive experience drafting and prosecuting patent applications in technologies related to immunotherapies, including recombinant vaccines using live, attenuated bacterial vectors to express proteins for cancer immunotherapy. My clients include leading biopharmaceutical companies, agricultural biotechnology companies, clinical stage biotechnology companies, and universities developing technologies ranging from genome editing platforms to transgenic plants to vaccines for treating cancer.Before joining Alston & Bird, I worked as a licensing assistant in the Office of Technology Transfer at North Carolina State University, where I assessed the marketability and patentability of biotechnology inventions, drafted agreements and marketed inventions to biotechnology companies.